Literature DB >> 27098243

CNS involvement in CMTX1 caused by a novel connexin 32 mutation: a 6-year follow-up in neuroimaging and nerve conduction.

Chong Xie1, Xiajun Zhou2, Desheng Zhu3, Wei Liu1, Xiaoqing Wang1, Hong Yang4, Zezhi Li2, Yong Hao2, Guang-Xian Zhang5, Yangtai Guan1,2.   

Abstract

X-linked Charcot-Marie-Tooth disease, type 1 (CMTX1) is one of the most common inherited neurological disorders. Obvious CNS involvement is relatively rare in CMTX1 patients. A 24-year-old male with CMTX1 presented with three transient stroke-like attacks, and was followed up regularly for 6 years with brain MRI and electrophysiological examination. Transient symmetrical high signals on T2 imaging and restricted diffusion were found in bilateral deep white matter. Electrophysiological measurement revealed a sensorimotor peripheral neuropathy with slightly reduced nerve conduction velocities. A novel thymine to cytosine mutation at nucleotide position 445 in the connexin 32 allele of the GJB1 gene was identified. During the 6-year longitudinal study, patient's motor and sensory function did not worsen; radiological abnormalities correlated with episodes of CNS dysfunction and resolved after clinical recovery; electrophysiological records showed no obvious change. Little change in the patient's clinical, radiological and electrophysiological results over the follow-up reflected a slow disease progression.

Entities:  

Keywords:  CNS involvement; Cx32 gene mutation; Nerve conduction velocity; Symmetrical white matter abnormalities; X-linked Charcot-Marie-Tooth disease

Mesh:

Substances:

Year:  2016        PMID: 27098243     DOI: 10.1007/s10072-016-2537-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  38 in total

1.  HMSN and HNPP. Laboratory service provision in the south west of England--two years' experience.

Authors:  M M Williams; L A Tyfield; P Jardine; P W Lunt; D L Stevens; P D Turnpenny
Journal:  Ann N Y Acad Sci       Date:  1999-09-14       Impact factor: 5.691

2.  Recurrent central nervous system white matter changes in charcot-Marie-tooth type X disease.

Authors:  Jennifer L McKinney; Emily C De Los Reyes; Warren D Lo; Kevin M Flanigan
Journal:  Muscle Nerve       Date:  2014-01-27       Impact factor: 3.217

3.  Genetic and clinical aspects of Charcot-Marie-Tooth's disease.

Authors:  H Skre
Journal:  Clin Genet       Date:  1974       Impact factor: 4.438

4.  Clinical and pathological observations in men lacking the gap junction protein connexin 32.

Authors:  A F Hahn; P J Ainsworth; C C Naus; J Mao; C F Bolton
Journal:  Muscle Nerve Suppl       Date:  2000

5.  Transient, recurrent, white matter lesions in X-linked Charcot-Marie-Tooth disease with novel connexin 32 mutation.

Authors:  C Oliver Hanemann; Carsten Bergmann; Jan Senderek; Klaus Zerres; Ann-Dorte Sperfeld
Journal:  Arch Neurol       Date:  2003-04

6.  Corticospinal tract MRI hyperintensity in X-linked Charcot-Marie-Tooth Disease.

Authors:  Jan Kassubek; Volker Bretschneider; Anne-Dorte Sperfeld
Journal:  J Clin Neurosci       Date:  2005-06       Impact factor: 1.961

7.  A novel deletion mutation in GJB1 causes X-linked Charcot-Marie-Tooth disease in a Han Chinese family.

Authors:  Pengfei Lin; Fei Mao; Qiji Liu; Wanling Yang; Changshun Shao; Chuanzhu Yan; Yaoqin Gong
Journal:  Muscle Nerve       Date:  2010-12       Impact factor: 3.217

8.  Clinical reasoning: a young man with reversible paralysis, cerebral white matter lesions, and peripheral neuropathy.

Authors:  Le Zhong; Kai Yan; Chentao Liu; Jinjie Xue; Lingqian Wu; Fei Yin
Journal:  Neurology       Date:  2012-08-21       Impact factor: 9.910

9.  Persistent CNS dysfunction in a boy with CMT1X.

Authors:  Carly Siskind; Shawna M E Feely; Saunder Bernes; Michael E Shy; James Y Garbern
Journal:  J Neurol Sci       Date:  2009-02-03       Impact factor: 3.181

10.  Episodic neurological dysfunction in hereditary peripheral neuropathy.

Authors:  Girish Baburao Kulkarni; Pooja Mailankody; Pawanraj Palu Isnwara; Chandrajit Prasad; Veerendrakumar Mustare
Journal:  Ann Indian Acad Neurol       Date:  2015 Jan-Mar       Impact factor: 1.383

View more
  7 in total

1.  Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01       Impact factor: 3.307

Review 2.  Atypical Pediatric Demyelinating Diseases of the Central Nervous System.

Authors:  Regina M Troxell; Alison Christy
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

Review 3.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

4.  Clinical and Genetic Features of Chinese X-linked Charcot-Marie-Tooth Type 1 Disease.

Authors:  Yuan-Yuan Lu; He Lyu; Su-Qin Jin; Yue-Huan Zuo; Jing Liu; Zhao-Xia Wang; Wei Zhang; Yun Yuan
Journal:  Chin Med J (Engl)       Date:  2017-05-05       Impact factor: 2.628

5.  Central Alteration in Peripheral Neuropathy of Trembler-J Mice: Hippocampal pmp22 Expression and Behavioral Profile in Anxiety Tests.

Authors:  Juan Pablo Damián; Lucia Vázquez Alberdi; Lucía Canclini; Gonzalo Rosso; Silvia Olivera Bravo; Mariana Martínez; Natalia Uriarte; Paul Ruiz; Miguel Calero; María Vittoria Di Tomaso; Alejandra Kun
Journal:  Biomolecules       Date:  2021-04-19

6.  Novel mutations in GJB1 trigger intracellular aggregation and stress granule formation in X-linked Charcot-Marie-Tooth Disease.

Authors:  Fan Chu; Jiaming Xu; Yong Wang; Yingjie Li; Yaling Wang; Zhijun Liu; Chuanzhou Li
Journal:  Front Neurosci       Date:  2022-09-26       Impact factor: 5.152

7.  The Electrophysiological Features in X-Linked Charcot-Marie-Tooth Disease With Transient Central Nervous System Deficits.

Authors:  Qingxian Wen; Longqiao Cao; Cun Yang; Yanchen Xie
Journal:  Front Neurol       Date:  2018-06-27       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.